Buck Elizabeth reported BDTX

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001880385-26-000002

Machine-readable

Structured copy

Timestamps

Event (reported)

Jan 21, 2026

Published

Jan 23, 2026

Ingested by INSIDER

Nov 5, 04:21 UTC

Last re-read

Nov 5, 04:21 UTC

Extracted facts

Filer

Buck Elizabeth

Role

CHIEF SCIENTIFIC OFFICER

Transaction

Grant or awardAs filed: “A”

Asset

Black Diamond Therapeutics, Inc. — Stock Option (Right to Buy)

Ticker

BDTX

Shares

250.0K

Price per share

$0

Execution date (reported)

Jan 21, 2026

Owned after transaction

250.0K shares

Days from execution to publication

2

What this establishes

Buck Elizabeth filed this Form 4 reporting a grant or award of BDTX on Jan 21, 2026. It became public on Jan 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

CHIEF SCIENTIFIC OFFICER

Buck Elizabethcik:0001880385

Issuer

Black Diamond Therapeutics, Inc.cik:0001701541

Revision history · 0

No field has changed since this record was first ingested.